Epistem says its focus on epithelial stem cell services and growth of its CRO and biomarker businesses helped it to stave off the downturn and post a strong set of financials of the fiscal year ended June 30.
Following a “significant increase in demand” GVK Biosciences has partnered with Quantitative Solutions (QS) to develop and market clinical trial outcome databases, which they believe can improve drug development.
French drug major Sanofi Aventis, Israel's Teva Pharmaceutical Industries and Germany’s Ratiopharm were raided by European Commission (EC) competition officials yesterday as part of an ongoing investigation.
GSK and Walvax have entered into a long-term joint venture (JV) to serve the Chinese vaccine market, with the big pharma transferring technology to enable local production and building a manufacturing plant.
Hospira has acquired the worldwide rights to filgrastim and a Croatian biologics plant from Pliva, increasing its presence in the biogenerics field, and told in-PharmaTechnologist that further expansions are possible.
Pharma’s reliance on outsourcing and products developed by biotechs could cause the pace of innovation to “decline considerably”, according to experts that are concerned about the lack of funding for small businesses.